These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8281962)

  • 1. Role of the cardiac renin-angiotensin system in hypertensive cardiac hypertrophy.
    Lee YA; Lindpaintner K
    Eur Heart J; 1993 Nov; 14 Suppl J():42-8. PubMed ID: 8281962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension.
    Devereux RB; Pickering TG; Cody RJ; Laragh JH
    J Clin Hypertens; 1987 Mar; 3(1):87-103. PubMed ID: 3033158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy.
    Raman VK; Lee YA; Lindpaintner K
    Am J Cardiol; 1995 Nov; 76(13):18D-23D. PubMed ID: 7495212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats.
    Ito N; Ohishi M; Yamamoto K; Tatara Y; Shiota A; Hayashi N; Komai N; Yanagitani Y; Rakugi H; Ogihara T
    Am J Hypertens; 2007 Jul; 20(7):792-9. PubMed ID: 17586415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the cardiac renin-angiotensin system in hypertensive heart disease].
    Holmer SR; Riegger GA
    Herz; 1995 Oct; 20(5):322-9. PubMed ID: 7498879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
    Lijnen P; Petrov V
    J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
    Sesin J; Tamargo J
    Medicina (B Aires); 1996; 56(1):75-84. PubMed ID: 8734937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist.
    Haddad GE; Blackwell K; Bikhazi A
    Can J Physiol Pharmacol; 2003 Feb; 81(2):142-9. PubMed ID: 12710528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
    Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiac renin-angiotensin system. From basic research to clinical relevance.
    Lee YA; Lindpaintner K
    Arzneimittelforschung; 1993 Feb; 43(2A):201-6. PubMed ID: 8498965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interference with the cardiac renin-angiotensin system.
    Becker RH; Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S10-5. PubMed ID: 2483422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin blocking drugs and the heart beyond 2000.
    Morgan TO; Delbridge LM
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S243-7. PubMed ID: 9892172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
    de Resende MM; Mill JG
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on local cardiac renin-angiotensin system.
    Ruzicka M; Leenen FH
    Curr Opin Cardiol; 1997 Jul; 12(4):347-53. PubMed ID: 9263646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracardiac generation of angiotensin and its physiologic role.
    Lindpaintner K; Jin M; Wilhelm MJ; Suzuki F; Linz W; Schoelkens BA; Ganten D
    Circulation; 1988 Jun; 77(6 Pt 2):I18-23. PubMed ID: 3286043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the cardiac renin-angiotensin system on hypertrophy].
    Ertl G; Schorb W; Gaudron P; Hu K
    Z Kardiol; 1996; 85 Suppl 6():233-40. PubMed ID: 9064970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiotensin-converting-enzyme inhibitor and heart hypertrophy].
    Riegger AJ; Kromer EP
    Wien Med Wochenschr; 1990 Jan; 140(1-2):46-9. PubMed ID: 2137956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats.
    Takemori K; Ishida H; Ito H
    Life Sci; 2005 Sep; 77(18):2233-45. PubMed ID: 15963533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.